Effects of Unilateral Compound Training on Lower-Limb Strength Asymmetry and Athletic Performance… (NCT07679815) | Clinical Trial Compass
CompletedNot Applicable
Effects of Unilateral Compound Training on Lower-Limb Strength Asymmetry and Athletic Performance in Female Handball Players
Turkey (Türkiye)30 participantsStarted 2025-11-15
Plain-language summary
Lower-limb strength asymmetry is common among female handball players and may negatively affect athletic performance while increasing injury risk. This randomized controlled trial was designed to investigate the effects of a six-week unilateral compound training program on lower-limb strength asymmetry, isokinetic muscle strength, hamstring-to-quadriceps ratio, body composition, and physical performance in competitive female handball players. Participants were randomly assigned to either an experimental group receiving unilateral compound training in addition to regular handball training or a control group continuing regular handball training only. It was hypothesized that unilateral compound training would reduce strength asymmetry and improve neuromuscular performance compared with regular training alone.
Who can participate
Age range
18 Years – 25 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female handball players aged 18-25 years.
* Competing in the Turkish Women's 2nd Handball League.
* Regular participation in team training (4 sessions/week) and official matches.
* Voluntary participation with written informed consent.
Exclusion Criteria:
* Current musculoskeletal injury or pain preventing participation in training.
* History of lower-limb surgery within the previous 12 months.
* Neurological, cardiovascular, or other medical conditions affecting exercise participation.
* Failure to complete the intervention or assessment procedures.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Lower-Limb Strength Asymmetry
Timeframe: Baseline and immediately after the 6-week intervention